2- (b) Schedules 7.01, 7.02, 7.03, 7.08 and 7.09 attached hereto shall replace in their entirety Sections 7.01(b), 7.02W), 7.03(b), 7.08 and 7.09 of the Confidential Disclosure Letter. Section 2. Conditions to Effectiveness (Relating to Establishment...Term Loan Credit Agreement • February 5th, 2015 • Prestige Brands Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 5th, 2015 Company Industry Jurisdiction